Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPRC | P08575 | 3/20 | 0.92 |
| ▸ | TTR | P02766 | 7/20 | 0.89 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.65 |
| ▸ | S100A4 | P26447 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.60 |
| ▸ | CDC25A | P30304 | 1/20 | 0.60 |
| ▸ | CDC25B | P30305 | 1/20 | 0.60 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | HTR7 | P34969 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4074222 | 0.96 | PTPRC (1.00) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL292802 | 0.96 | TTR (0.96) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL30610011 | 0.94 | TTR (1.00) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL123492 | 0.94 | TTR (1.00) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL11877439 | 0.92 | TTR (0.96) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL6261915 | 0.92 | PTPRC (1.00) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL28446002 | 0.92 | TTR (0.96) | PTPRCTTRCHEK1S100A4KMT2A | |
| Hydrochloric Acid SCHEMBL3453762 | 0.92 | TTR (0.96) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL29917994 | 0.92 | TTR (0.96) | PTPRCTTRCHEK1S100A4KMT2A | |
| SCHEMBL28081049 | 0.92 | TTR (0.96) | PTPRCTTRCHEK1S100A4KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023183405-A2 | PHARMACEUTICAL COMPOUNDS FOR THE TREATMENT OF COMPLEMENT MEDIATED DISORDERS | ALEXION PHARMACEUTICALS, INC. (US) | 2023-09-28 | — | — | WO | disclosed |
| US-20230213863-A1 | COMPOUND, RESIST UNDERLAYER FILM COMPOSITION INCLUDING SAME, AND RESIST UNDERLAYER FILM | DONGJIN SEMICHEM CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-20230213863-A1 | COMPOUND, RESIST UNDERLAYER FILM COMPOSITION INCLUDING SAME, AND RESIST UNDERLAYER FILM | DONGJIN SEMICHEM CO., LTD. (KR) | 2023-07-06 | — | — | US | disclosed |
| US-11215935-B2 | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2022-01-04 | — | — | US | disclosed |
| US-11169455-B2 | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20200341392-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJI XEROX CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| US-20200341393-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJI XEROX CO., LTD. (JP) | 2020-10-29 | — | — | US | disclosed |
| US-10754266-B2 | Electrophotographic photoreceptor, process cartridge, and image forming apparatus | FUJI XEROX CO., LTD. (JP) | 2020-08-25 | — | — | US | disclosed |
| US-20200096884-A1 | ELECTROPHOTOGRAPHIC PHOTORECEPTOR, PROCESS CARTRIDGE, AND IMAGE FORMING APPARATUS | FUJI XEROX CO.,LTD. (JP) | 2020-03-26 | — | — | US | disclosed |
| US-7858824-B2 | Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them | SANOFI-AVENTIS (FR) | 2010-12-28 | — | — | US | disclosed |
| CN-1571770-A | Aralkyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them | SANOFI SYNTHELABO (FR) | 2005-01-26 | — | — | CN | disclosed |
| US-20050014795-A1 | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | SANOFI-SYNTHELABO (FR) | 2005-01-20 | — | — | US | disclosed |
| US-6284365-B1 | FOR CONTROLLING PHYSICAL PROPERTIES OF SURFACE AND INTERFACE OF SOLID ARTICLE SUCH AS WETTABILITY, ADHESIVE PROPERTY, SURFACE ENERGY, DISPERSABILITY, CHEMICAL RESISTANCE | FUJI XEROX CO., LTD. (JP) | 2001-09-04 | — | — | US | disclosed |
| US-5286603-A | Substrate coated with a photopolymerizable compound containing ethylenic unsaturation, a perester photoinitiator and optionally an optical sensitizer | VICKERS PLC (GB) | 1994-02-15 | — | — | US | disclosed |
| US-5130227-A | Multilayer light sensitive plates | VICKERS PLC (GB) | 1992-07-14 | — | — | US | disclosed |
| US-4946960-A | ADDITION POLYMERIZATION CATALYSTS | VICKERS PLC (GB) | 1990-08-07 | — | — | US | disclosed |
| EP-0125140-B1 | IMPROVEMENTS IN OR RELATING TO RADIATION SENSITIVE PLATES | VICKERS PLC (GB) | 1988-12-14 | — | — | EP | disclosed |
| EP-0125875-B1 | IMPROVEMENTS IN OR RELATING TO PERESTER COMPOUNDS | VICKERS PLC (GB) | 1988-08-10 | — | — | EP | disclosed |
| EP-0125875-A2 | Improvements in or relating to perester compounds | VICKERS PLC (GB) | 1984-11-21 | — | — | EP | disclosed |
| EP-0125140-A2 | Improvements in or relating to radiation sensitive plates | VICKERS PLC (GB) | 1984-11-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014795-A1 | Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same | CYCS, NADK, CYP2F1 | PTPRC 2743/4885TTR 778/4885CHEK1 1204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.